Ay. Nikitin et al., WILD-TYPE NEU TRANSGENE COUNTERACTS MUTANT HOMOLOG IN MALIGNANT TRANSFORMATION OF RAT SCHWANN-CELLS, Oncogene, 12(6), 1996, pp. 1309-1317
Mutational activation of the neu (erbB-2) receptor protein tyrosine ki
nase gene appears to be the triggering event in the process of oncogen
esis induced by N-ethyl-N-nitrosourea (EtNU) in immature Schwann cells
of the rat peripheral nervous system. Subsequent loss of the wild-typ
e neu allele may represent a critical secondary step towards malignanc
y. Developmentally-regulated expression of a wild-type rat neu transge
ne (neu cDNA under the control of the rat P-o promotor) in the Schwann
cells of transgenic BDIX and Sprague-Dawley rats exposed to EtNU on p
ostnatal day 1 results in a lower incidence of early atypical prolifer
ates in the trigeminal nerve. Furthermore, re-introduction of the wild
-type neu gene into homozygous neu mutant schwannoma cells counteracts
the expression of the tumorigenic phenotype. The suppressive action o
f the wild-type gene over its mutationally activated oncogenic homolog
ue underlines the critical function of the neu gene in the control of
differentiation in the Schwann cell lineage, and provides evidence for
the responsiveness of cellular phenotypes towards quantitative shifts
in the dosage of wild-type vs mutant signal transducing molecules.